BPC-157 / TB-500
| Specifications | |
|---|---|
| Presentation | 10 mg / 10 mg |
| Classification | Dual-peptide lyophilized formulation |
| Form | Lyophilized powder |
| Purity (HPLC) | Verified per lot - see COA |
| Batch / Lot | pending |
About this material
This dual-peptide formulation combines BPC-157, a 15-amino acid synthetic peptide fragment, with TB-500, a 43-amino acid synthetic peptide corresponding to the active region of the naturally occurring thymosin beta-4 protein. Each peptide is independently manufactured using precision Solid-Phase Peptide Synthesis (SPPS) under controlled production parameters designed to ensure high sequence fidelity, molecular consistency, and reproducible batch quality. Following synthesis, both peptide components are purified using High-Performance Liquid Chromatography (HPLC) before formulation into a chemically defined lyophilized preparation.
Each production batch undergoes comprehensive analytical characterization to verify the molecular identity of both peptide components, chromatographic purity, peptide content, formulation consistency, and overall physicochemical quality prior to release. Standardized manufacturing and formulation controls support reproducible batch quality and compositional uniformity. Every production lot is accompanied by a batch-specific Certificate of Analysis (COA) documenting analytical verification, quality control review, and complete manufacturing traceability, providing a well-characterized dual-peptide material for scientific and analytical laboratory investigations.
